Navigation Links
Edwards Lifesciences Announces First Human Implants of Next-Generation Transcatheter Heart Valve
Date:3/5/2008

ese forward-looking statements include, but are not limited to, the timing and progress of clinical studies relating to the company's transcatheter valve technologies and the market opportunity for transcatheter technologies. Forward-looking statements are based on estimates and assumptions made by management of the company and are believed to be reasonable, though they are inherently uncertain and difficult to predict.

Forward-looking statements involve risks and uncertainties that could cause actual results or experience to differ materially from that expressed or implied by the forward-looking statements. Factors that could cause actual results or experience to differ materially from that expressed or implied by the forward-looking statements are detailed in the company's filings with the Securities and Exchange Commission including its Annual Report on Form 10-K for the year ended December 31, 2007.

Edwards, Edwards SAPIEN and RetroFlex are trademarks of Edwards Lifesciences Corporation. Edwards Lifesciences, the stylized E logo, Ascendra, CardioVations, Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.


'/>"/>
SOURCE Edwards Lifesciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Edwards Lifesciences Announces Organizational Changes
2. Edwards Lifesciences to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
3. Edwards Lifesciences to Host Earnings Conference Call on February 5, 2008
4. Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve
5. Edwards Lifesciences Completes Acquisition of CardioVations Product Line
6. Edwards Lifesciences Forecasts Strong Growth in 2008
7. Marshall Edwards, Inc. to Present at BIO Investor Forum 2007
8. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
9. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
10. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
11. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9
Breaking Biology News(10 mins):Researchers demonstrate nanoscale X-ray imaging of bacterial cells 2AACR names Perou 2009 Outstanding Investigator for Breast Cancer Research 2Genome BC collaborates with Chile and Norway to sequence salmon genome 2Los Angeles Kerlan Jobe Orthopaedic Clinic Pays 243 Million to Settle Kickback Allegations 62394 1Los Angeles Kerlan Jobe Orthopaedic Clinic Pays 243 Million to Settle Kickback Allegations 62394 2Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 1Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 2Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 3Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 4Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 5Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 6Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 7Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 8Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 9Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 10Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 11Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 12Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 13Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 14Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 15Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 16Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 17Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 18Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 19Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 20Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 21Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 22Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 23Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 24Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 25Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 26Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 27Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 1Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 2Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 3Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 4Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 5Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 6Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 7Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 8Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 9Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 10Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 11Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 12Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 13Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 14